ASTMH 2011

[December 4-8, 2011]
Philadelphia, USA
DNDi participated with presentations on the Leishmaniasis East Africa Platform and on Chagas disease, as well as with several posters and a DNDi booth.

DNDi Partners’ meeting 2011, Rio de Janeiro

[December 2, 2011]
‘Moving Innovation to Access for Neglected Patients’
Rio de Janeiro, Brazil
This year marks nearly a decade of progress since the foundations for DNDi were set forth at a remarkable meeting in Rio in 2002. Just nine years later, we come together again to review DNDi’s progress in bringing new treatments to neglected patients as well as to evaluate the main challenges in access to new tools.

ASMQ Meeting

[December 1st, 2011]
Rio de Janeiro
The meeting “Artesunate-Mefloquine (ASMQ) Fixed-Dose Combination (FDC), an additional tool in the armamentarium to control malaria in Latin-America” was held in parallel with DNDi‘s annual partners’ meeting in Rio de Janeiro.

World Health Summit

[October 23-26, 2011]
Berlin, Germany
DNDi co-organized a session on Product Development for Neglected Patients and took part to the Innovation session.

Check here for the detailed presentation of the symposia, with speakers.

6th EDCTP Forum

[October 9 – 12, 2011]
Addis Ababa, Ethiopia
DNDi attended the Forum whose theme for 2011 was “Strengthening Research Partnerships for Better Health and Sustainable Development”

31st Conference of the ISCTRC

[September 12-16, 2011]
Bamako, Mali
DNDi attended the 31st Conference of the International Scientific Council for Trypanosomiasis Research and Control (ISCTRC) in the session on HAT chemotherapy.

IAS 2011

[July 17-20, 2011]
Rome, Italy
With the expansion of its portfolio to paediatric HIV, DNDi attended the IAS conference to advocate on R&D needs for better adapted drugs for infants

ISID-NTD Meeting

[July 8-10, 2011]
Boston, USA
DNDi attended the firsts NTD meeting of ISID in the following sessions: “Developing the Tools Needed to Fight NTDs” and “Essential Elements: Drug Donations and Nongovernmental Development Programs”